Wirtschaftspolitik für wissensintensive Branchen am Beispiel der Pharmaindustrie

Jörg Mahlich ()

Zeitschrift für Wirtschaftspolitik, 2005, vol. 54, issue 3, 366-390

Abstract: Against the background of decreasing competitiveness of German pharmaceutical firms, we analyze the impact of institutional framework conditions on the performance of research-based pharmaceutical enterprises. Reviewing the literature, we find ample empirical evidence that both strict price regulation and a rigorous drug approval process lower the expected returns of new drug introductions and therefore reduce the incentives of R&D investments. A reliable patent system on the other hand constitutes a regulatory measure that enhances firm R&D investments and thereby generates a positive economic impact.

Date: 2005
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://doi.org/10.1515/zfwp-2005-0306 (text/html)
For access to full text, subscription to the journal or payment for the individual article is required.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:lus:zwipol:v:54:y:2005:i:3:p:366-390:n:6

Ordering information: This journal article can be ordered from
https://www.degruyter.com/journal/key/zfwp/html

DOI: 10.1515/zfwp-2005-0306

Access Statistics for this article

Zeitschrift für Wirtschaftspolitik is currently edited by Juergen B. Donges, Steffen J. Roth, Achim Wambach and Christian Watrin

More articles in Zeitschrift für Wirtschaftspolitik from De Gruyter
Bibliographic data for series maintained by Peter Golla ().